Black Rock Inc. G1 Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,082,031 shares of GTHX stock, worth $22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,082,031
Previous 672,027
358.62%
Holding current value
$22 Million
Previous $2.9 Million
142.06%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding GTHX
# of Institutions
54Shares Held
11MCall Options Held
1.85MPut Options Held
1.18M-
Jacobs Levy Equity Management, Inc Florham Park, NJ464KShares$3.31 Million0.0% of portfolio
-
Tekla Capital Management LLC424KShares$3.03 Million0.04% of portfolio
-
Readystate Asset Management LP Chicago, IL199KShares$1.43 Million0.01% of portfolio
-
Virtu Financial LLC New York, NY74.4KShares$531,6310.01% of portfolio
-
Jane Street Group, LLC New York, NY64.9KShares$464,1490.0% of portfolio
About G1 Therapeutics, Inc.
- Ticker GTHX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,746,800
- Market Cap $306M
- Description
- G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...